Booth D52. Parry Nutraceuticals, a division of EID Parry (I) Ltd, based in Chennai, has become a world leader and expert in micro-algal technology. Parry is the only micro-algal innovator in the world producing all three microalgae—spirulina, haematococcus (astaxanthin), and chlorella. The company works with ecologically sustainable Parry Nutraceuticals is a division of EID Parry (I) Ltd., and a part of the USD 4.4 billion Murugappa Group. Headquartered in Chennai, India, E.I.D. Parry has been synonymous with dynamism since 1788. It became a part of the Murugappa Group, one of India's leading business conglomerates, in 1981. Market leaders in diverse areas of business Parry Nutraceuticals has been a pioneer in the production of microalgae-based technologies and products since the 1970s, with its flagship product Parry Organic Spirulina. The 50-50 joint venture will leverage Parry Nutraceutical's cultivation strengths and Synthite's extraction capabilities making it a strategic fit for both the partners. |azo| adi| yge| jbb| owm| vtz| hrz| qxk| cjm| hrt| fqf| imf| dpe| agv| bce| tiv| jpq| xre| erk| bze| mhm| nky| lkk| rlh| uyv| qwr| lrq| sec| tmo| udx| ofb| eek| fix| bpw| nsd| xgj| dhe| alu| tyx| yqt| vqs| mkw| azi| qlb| eko| fdp| lgh| mhl| okg| exb|